July 9, 2007 – biospace med has filed a 510k application with the FDA to market the EOS ultra-low dose 2D/3D orthopedic X-ray imager in the U.S. The imager recently received the European CE mark and the device is also available in Canada.
The EOS ultra-low dose 2D/3D is based upon a patented particle detector technology for which Georges Charpak received the Nobel Prize in Physics. According to the company, the detector, which allows images to be obtained with a low dose of radiation, is part of a system that is capable of very long length digital imaging, permitting full-body, uninterrupted digital imaging with a single scan. Multiplanar images, including frontal and side images, can be obtained simultaneously in about 20 seconds with the patient in an upright, weight-bearing position.
For more information: www.biospace.fr/biospace_us/home_med.php
May 17, 2024 
